Factors influencing the outcomes of patients with both coronary artery disease and diabetes enrolled in standard cardiac rehabilitation programs: A literature review

Journal of Cardiovascular Nursing

Volumn 26, Issue 3, 2011, Pages 210-217

  Miketic, Joyce K ^a,b   Hravnak, Marilyn ^a   Stilley, Carol S ^a   Robertson, Robert J ^a   Sereika, Susan M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh ^*  (United States)

Author keywords

Cardiac rehabilitation; coronary artery bypass graft; functional outcomes; rehabilitation outcomes; revascularization; type 2 diabetes mellitus

Indexed keywords

ADULT; COMORBIDITY; CORONARY ARTERY DISEASE; DAILY LIFE ACTIVITY; DIABETES MELLITUS; EXERCISE; HEART MUSCLE REVASCULARIZATION; HUMAN; PATIENT COMPLIANCE; REVIEW; TREATMENT OUTCOME; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADULT; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; EXERCISE; HUMANS; MYOCARDIAL REVASCULARIZATION; PATIENT COMPLIANCE; TREATMENT OUTCOME; UNITED STATES;

EID: 79955108012     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e31820017dc     Document Type: Review

References (50)

1. American Diabetes Association. Standards of medical care in diabetesV2010. Diabetes Care. 2010;33(S1):S11-S61.
2. Songer TJ. Studies on the Costs of Diabetes. Atlanta, GA: Centers for Disease Control and Prevention; Division of Diabetes Translation; 1998:259-282.
3. Boyle JP, Honeycut AA, Venkat-Narayan KM, et al. Projection of diabetes burden through 2050. Diabetes Care. 2001;24(11):1936-1940.
4. American Diabetes Association. Economic costs of diabetes in the United States in 2002. Diabetes Care. 2003;26(3): 917-943.
5. US Department of Health and Human Services. Diabetes, Disabling Disease to Double by 2050. Atlanta, GA: CDC; Coordinating Center for Health Promotion. 2008;1:1-4.
6. Grundy SM, Howard B, Smith S, et al. Prevention Conference VI: diabetes and cardiovascular disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Chest. 2002;105:2231-2239. (Pubitemid 34517172)
7. Bergenstal RM, Bloomgarden Z, Charron-Prochownik D. Understanding Cardiometabolic Risk: Broadening Risk Assessment and Management. Alexandria, VA: American Diabetes Association; 2007.
8. National Center for Chronic Disease Prevention and Health. Leading health indicators. 2008. http://www. healtH-people.gov. Accessed July 12, 2008.
9. National Center for Health Statistics. Diabetes statistics. 2008. http://www.cdc.gov/nchs/fastats/diabetes.htm. Accessed February 22, 2009.
10. National Center for Chronic Disease Prevention and Health. HealtH- People 2020 Public Meetings 2009 draft objectives. 2009. http://www.healtH-people.gov/ HP2020/. Accessed September 13, 2010.
11. Egede LE, Zheng D. Modifiable cardiovascular risk factors in adults with diabetes. Arch Intern Med. 2002;162:427-433.
12. Gu K, Crowie CC, Harris MI. Diabetes and decline in heart diseasemortality in US adults. JAMA. 1999;281:1291-1297. (Pubitemid 29174480)
13. Sahakyan K, Abranson JL, Krumholz HM, Vaccarino V. Comparison of functional status after coronary artery bypass grafting in patients with and without diabetes mellitus. Am J Cardiol. 2006;98:619-623. (Pubitemid 44251197)
14. Julien J. Cardiac complications in nonYinsulin dependent diabetes mellites. J Diabet Complications. 1997;11(2):123-130. (Pubitemid 27163209)
15. Egede LE. Diabetes, major depression, and functional disability among US adults. Diabetes Care. 2004;27:421-428. (Pubitemid 38174067)
16. Verges B, Patois-Verges B, Cohen M. Effects of cardiac rehabilitation on exercise capacity in type 2 diabetic patients with coronary artery disease. Diabet Med. 2004;21: 889-895. (Pubitemid 39037003)
17. Hindman L, Falko JM, LaLonde M, Snow R, Caulin- Glaser T. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation. Am Heart J. 2005;150:1046-1051. (Pubitemid 41607796)
18. Gregg EW, Beckles GL, Williamson DF, et al. Diabetes and pH-sical disability among older US adults. Diabetes Care. 2000;23:1272-1277.
19. Gregg EW, Mangione CM, Cauley JA, et al. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002;25:61-67. (Pubitemid 41070784)
20. Blaum CS, Ofstedal MB, Langa KM, Wray LA. Functional status and health outcomes in older Americans with diabetes mellitus. J Am Geriatr Soc. 2003;51:745-753. (Pubitemid 36693422)
21. Von Koref M, Katon W, Lin EH, et al. Work disability among individuals with diabetes. Diabetes Care. 2005;28: 1326-1332. (Pubitemid 40756692)
22. Mayfield JA, Deb P, Whitecotton L. Work disability, and diabetes. Diabetes Care. 1999;22:1105-1109.
23. Sanderson BK, Shewchuk RM, Bittner V. Cardiac rehabilitation and women. J Cardiopulm Rehabil Prev. 2010;30:12-21.
24. American Diabetes Association /American College of Cardiology. Prescribing pH-sical activity for the management of cardiovascular disease and diabetes. Diabetes Cardiovasc Rev. 2004;8:1-7.
25. Chipkin SR, Klugh SA, Chasan-Taber L. Exercise and diabetes. Cardiol Clin. 2001;19(3):1-22.
26. Eyre H, Kahn R, Robertson RM. Preventing cancer, cardiovascular disease and diabetes. Diabetes Care. 2004;27(7): 1812-1824.
27. Cauza E, Hanusch-Enserer U, Strasser B, et al. The metabolic effects of long term exercise in type 2 diabetes patients. Wien Med Wochenschr. 2006;156(17-18):515-519. (Pubitemid 44622130)
28. Tekin G, Tekin A, Canatar T. Simvastatin improves attenuated heart rate recovery of type 2 diabetics. Pharmacol Res. 2006;54:442-446. (Pubitemid 46053820)
29. Loimaala A, Huikuri HV, Koobi T, et al. Exercise training improves baroreflex sensitivity in type 2 diabetes. Diabetes. 2003;52:1837-1842. (Pubitemid 36792476)
30. Sigal RJ, Kenny GP, Boule NG, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes. Ann Intern Med. 2007;147:357-369. (Pubitemid 351664536)
31. Barrett JE, Plotnikoff RC, Courneya KS, Raine KD. PH-sical activity and type 2 diabetes. Diabetes Educ. 2007;33(1): 128-143.
32. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134-1146. (Pubitemid 29416243)
33. Rosano GM, Vitale C, Fragasso G. Metabolic therapy for patients with diabetes mellitus and coronary artery disease. Am J Cardiol. 2006;98(suppl):14J-18J.
34. George PB, Tobin KJ, Corpus RA, et al. Treatment of cardiac risk factors in diabetic patients: how well do we follow the guidelines. Am Heart J. 2001;142:857-856.
35. Bowden DW, Rudock M, Ziegler J, et al. Coincident linkage of type 2 diabetes, metabolic S-ndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes. 2006;55:1985-1994. (Pubitemid 44509971)
36. Rachmani R, Levi Z, Slavachevski I, Avin M, Ravid M. Teaching patients to monitor their risk factors retards the progression of vascular complication in high-risk patients with type 2 diabetes mellitus- a randomized prospective study. Diabetes Med. 2002;19:385-392. (Pubitemid 34534213)
37. Saydah S, Franklin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342. (Pubitemid 38101606)
38. Mehler PS, Esler A, Estacio RO, et al. Lack of improvement in the treatment of H-perlipidemia among patient with type 2 diabetes. Am J Med. 2003;114:377-382. (Pubitemid 36513686)
39. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization. JAMA. 2005;293:1501-1508. (Pubitemid 40393296)
40. Yu C, Lau C, Cheung B, et al. Clinical predictors of morbidity and mortality in patients with myocardial infarction or revascularization who underwent cardiac rehabilitation, and importance of diabetes mellitus and exercise capacity. Am J Cardiol. 2000;85:344-349. (Pubitemid 30052908)
41. Anselmino M, Malmberg K, Ohrvik J. Evidence-based medication and revascularization: powerful tool in the management of patients with diabetes and coronary artery disease: a report from the Euro heart survey on diabetes and the heart. J Cardiopulm Rehabil Prev. 2008;15:16-223.
42. Pennell L, Smith-S-nder CM, Hudson LR, Hamar GB, Westerfield J. Practice changes in glycemic management and outcomes in coronary artery bypass surgery patients. J Cardiovasc Nurs. 2005;20(1):26-34.
43. Dylewicz P, Bienkowska S, Szczesniak L, et al. Beneficial effect of short term endurance training on glucose metabolism during rehabilitation after coronary bypass surgery. Chest. 2000;117:47-51. (Pubitemid 30053619)
44. Banzer JA, Maguire TE, Kennedy CM, O'Malley CJ, Balady GJ. Results of cardiac rehabilitation in patients with diabetes mellitus. Am J Cardiol. 2004;93:81-84. (Pubitemid 38022039)
45. Soja AM, Zwisler AD, Frederiksen M, et al. Use of intensified comprehensive cardiac rehabilitation to improve risk factor control in patients with type 2 diabetes mellitus or impaired glucose tolerance-the randomized DANish StUdy of impaired glucose metabolism in the settings of cardiac rehabilitation (DANSUK) study. Am Heart J. 2007; 153:621-628. (Pubitemid 46442807)
46. Lavie CJ, Milani RV. Cardiac rehabilitation and exercise training programs in metabolic S-ndrome and diabetes. Card Rehabil Exerc Train. 2005;25:59-66.
47. Milani RV, Lavie CJ. Behavioral differences and effects of cardiac rehabilitation in diabetic patients following cardiac events. Am J Med. 1996;100:517-523. (Pubitemid 26170475)
48. Maniar S, Sanderson BK, Bittner V. Comparison of baseline characteristics and outcomes in younger and older patients completing cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2009;29:220-229.
49. Mourot L, Boussuges A,Maunier S, et al. Cardiovascular rehabilitation in patients with diabetes. J Cardiopulm Rehabil Prev. 2010;30:157-164.
50. VPller H, Reibis R, Pittrow D, et al. Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment. Curr Med Res Opin. 2009;25:879-890.